Lewy Bodies Study for Those Experiencing Visual Hallucinations (VH)
Official Title
A Phase 2, double-blind, randomized, placebo-controlled cross-over study of nelotanserin versus placebo in Lewy body dementia (LBD) subjects experiencing visual hallucinations (VH)
Purpose
Purpose: To assess the safety of using a drug called nelotanserin with those who have dementia with Lewy body with visual hallucinations.
Could this study be right for you?
- Age: 50-85
- Diagnosis: dementia with Lewy bodies (DLB) or Parkinson's disease dementia (PDD), presence of visual hallucinations that occur more days than not.
- MMSE Score: greater than or equal to 18 (Mini-Mental State Exam--Coordinator will explain)
- Must have a study partner willing to attend visits and ensure compliance with the study